Cited by 289Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.

Intrathecal Chemokine Synthesis in Mild Cognitive Impairment and Alzheimer Disease

Open access

Galimberti, Daniela, Schoonenboom, Niki, Scheltens, Philip, Fenoglio, Chiara, Bouwman, Femke, Venturelli, Eliana, Guidi, Ilaria, Blankenstein, Marinus A., Bresolin, Nereo, Scarpini, Elio·2006·Archives of Neurology

DOI 10.1001/archneur.63.4.538

Open this paper in CoChat — free account

Abstract

BACKGROUND: Immunoreactivity for several chemokines and for their related receptors has been demonstrated in resident cells of the central nervous system, and the up-regulation of some of them is associated with pathological changes found in Alzheimer disease (AD). OBJECTIVE: To determine interferon-gamma-inducible protein 10 (IP-10), monocyte chemotactic protein 1 (MCP-1), and interleukin 8 (IL-8) levels in cerebrospinal fluid (CSF) from subjects with amnestic mild cognitive impairment (MCI) and patients with AD as compared with age-matched controls. PATIENTS: Thirty-eight subjects with amnestic MCI, 36 patients with AD, and 41 age-matched subjects with noninflammatory affections of the nervous system. DESIGN: Evaluation of CSF chemokine production at time of diagnosis of MCI and AD; correlation with clinical and personal data. Longitudinal evaluation of subjects with MCI until conversion to AD. RESULTS: Cerebrospinal fluid IP-10 concentration was significantly increased in patients with MCI and mild AD but not in patients with severe AD (Mini-Mental State Examination score <15), whereas MCP-1 and IL-8 levels were increased in patients with MCI and all patients with AD. A significant positive correlation between Mini-Mental State Examination score and CSF IP-10 or MCP-1 concentration was observed in patients with AD. No correlation between IP-10 levels and age was found, whereas MCP-1 and IL-8 levels correlated positively with age. Out of 38 subjects with MCI, 19 developed AD within a 1- to 3-year follow-up. CONCLUSIONS: The presence of inflammatory molecules is likely to be a very early event in AD pathogenesis, even preceding the clinical onset of the disease, as demonstrated by subjects with MCI who developed AD over time. Interferon-gamma-inducible protein 10 is specifically increased in MCI and seems to decrease with the progression of AD, whereas MCP-1 and IL-8 are up-regulated also in late stages of the disease, suggesting a role in phases in which neurodegeneration is prevalent.

Integrity signals

Registry

Crossref · 10.1001/archneur.63.4.538

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
Current concepts in mild cognitive impairment
Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines.
Baggiolini, M., Dewald, B., & Moser, B. (1994) · PubMed · Cited by 2,232
Mild Cognitive Impairment Represents Early-Stage Alzheimer Disease
Morris, J. C., Storandt, M., Miller, J. P., McKeel, D. W., Price, J. L., Rubin, E. H., & Berg, L. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.397 · Cited by 1,871
Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)
Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N., & Ihara, Y. (1994) · Neuron · doi:10.1016/0896-6273(94)90458-8 · Cited by 1,774
Mild Cognitive Impairment as a Clinical Entity and Treatment Target
Petersen, R. C., & Morris, J. C. (2005) · Archives of Neurology · doi:10.1001/archneur.62.7.1160 · Cited by 935
Improved discrimination of AD patients using β-amyloid (1-42) and tau levels in CSF
Hulstaert, F., Blennow, K., Ivanoiu, A., Schoonderwaldt, H. C., Riemenschneider, M., Deyn, P. P. D., Bancher, C., Cras, P., Wiltfang, J., Mehta, P. D., et al. (1999) · Neurology · doi:10.1212/wnl.52.8.1555 · Cited by 724

Flagged first, then by citations

Show all 37 references

1 of the 37 references couldn’t be matched to a known paper.

Sorted by citations

A Meta-Analysis of Cytokines in Alzheimer's Disease
Swardfager, W., Lanctôt, K., Rothenburg, L., Wong, A., Cappell, J., & Herrmann, N. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.012 · Cited by 1,108
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
Ray, S., Britschgi, M., Herbert, C., Takeda-Uchimura, Y., Boxer, A., Blennow, K., Friedman, L. F., Galasko, D. R., Jutel, M., Karydas, A., et al. (2007) · Nature Medicine · doi:10.1038/nm1653 · Cited by 1,048
The blood-brain barrier in Alzheimer’s disease
Zenaro, E., Piacentino, G., & Constantin, G. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.007 · Cited by 767
Mediterranean Diet and Mild Cognitive Impairment
Scarmeas, N., Stern, Y., Mayeux, R., Manly, J. J., Schupf, N., & Luchsinger, J. A. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.536 · Cited by 757
sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers
Suárez‐Calvet, M., Kleinberger, G., Araque Caballero, M. Á., Brendel, M., Rominger, A., Alcolea, D., Fortea, J., Lleó, A., Blesa, R., Gispert, J. D., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201506123 · Cited by 522
Current state of Alzheimer’s fluid biomarkers
Molinuevo, J. L., Ayton, S., Batrla, R., Bednar, M. M., Bittner, T., Cummings, J., Fagan, A. M., Hampel, H., Mielke, M. M., Mikulskis, A., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1932-x · Cited by 518
Self-citation
Body Fluid Cytokine Levels in Mild Cognitive Impairment and Alzheimer’s Disease: a Comparative Overview
Brosseron, F., Krauthausen, M., Kummer, M., & Heneka, M. T. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8657-1 · Cited by 447
Transcranial direct current stimulation improves recognition memory in Alzheimer disease
Ferrucci, R., Mameli, F., Guidi, I., Mrakic-Sposta, S., Vergari, M., Marceglia, S., Cogiamanian, F., Barbieri, S., Scarpini, E., & Priori, A. (2008) · Neurology · doi:10.1212/01.wnl.0000317060.43722.a3 · Cited by 448
Self-citation
The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease
Minter, M. R., Taylor, J. M., & Crack, P. J. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13411 · Cited by 451
The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases
Conductier, G., Blondeau, N., Guyon, A., Nahon, J., & Rovère, C. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.05.010 · Cited by 419
Deletion of tumor necrosis factor death receptor inhibits amyloid β generation and prevents learning and memory deficits in Alzheimer's mice
He, P., Zhong, Z., Lindholm, K., Berning, L., Lee, W., Lemere, C., Staufenbiel, M., Li, R., & Shen, Y. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200705042 · Cited by 390
Neuroinflammation: Implications for the Pathogenesis and Molecular Diagnosis of Alzheimer's Disease
Rojo, L. E., Fernández, J. A., Maccioni, A. A., Jimenez, J. M., & Maccioni, R. B. (2008) · Archives of Medical Research · doi:10.1016/j.arcmed.2007.10.001 · Cited by 351
CXCR3 ligands in disease and therapy
Raemdonck, K. V., den Steen, P. E. V., Liekens, S., Damme, J. V., & Struyf, S. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.11.009 · Cited by 313
Diet and Alzheimer’s disease risk factors or prevention: the current evidence
Solfrizzi, V., Panza, F., Frisardi, V., Seripa, D., Logroscino, G., Imbimbo, B. P., & Pilotto, A. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.56 · Cited by 310
Glial activation and inflammation along the Alzheimer’s disease continuum
Nordengen, K., Kirsebom, B.-E., Henjum, K., Selnes, P., Gísladóttir, B., Wettergreen, M., Torsetnes, S. B., Grøntvedt, G. R., Waterloo, K. K., Aarsland, D., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1399-2 · Cited by 274
Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis
Bagyinszky, E., Giau, V. V., Shim, K., Suk, K., An, S. S. A., & Kim, S. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.03.031 · Cited by 276
Manifestations of systemic lupus erythematosus.
Cojocaru, M., Cojocaru, I. M., Siloşi, I., & Vrabie, C. D. (2011) · PubMed Central · Cited by 261
Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: A systematic review of biomarker studies
Stuart, M. J., & Baune, B. T. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.02.001 · Cited by 266
Monocyte Chemoattractant Protein‐1 Plays a Dominant Role in the Chronic Inflammation Observed in Alzheimer's Disease
Sokolova, A., Hill, M. D., Rahimi, F., Warden, L. A., Halliday, G. M., & Shepherd, C. E. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00188.x · Cited by 249
Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children
Armah, H. B., Wilson, N. O., Sarfo, B. Y., Powell, M. D., Bond, V. C., Anderson, W. A., Adjei, A. A., Gyasi, R. K., Tettey, Y., Wiredu, E. K., et al. (2007) · Malaria Journal · doi:10.1186/1475-2875-6-147 · Cited by 239
Molecular biomarkers of Alzheimer's disease: progress and prospects
Lashley, T., Schott, J. M., Weston, P. S. J., Murray, C. E., Wellington, H., Keshavan, A., Foti, S. C., Foiani, M. S., Toombs, J., Rohrer, J. D., et al. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.031781 · Cited by 251
Circulating miRNAs as Potential Biomarkers in Alzheimer's Disease
Galimberti, D., Villa, C., Fenoglio, C., Serpente, M., Ghezzi, L., Cioffi, S. M. G., Arighi, A., Fumagalli, G., & Scarpini, E. (2014) · Journal of Alzheimer’s Disease · doi:10.3233/jad-140756 · Cited by 222
Self-citation
Biomarkers of Oxidative Damage and Inflammation in Alzheimer's Disease
Galasko, D. R., & Montine, T. J. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.09.89 · Cited by 231
Infiltrating CD8+ T cells exacerbate Alzheimer’s disease pathology in a 3D human neuroimmune axis model
Jorfi, M., Park, J., Hall, C. K., Lin, C.-C. J., Chen, M., von Maydell, D., Kruskop, J. M., Kang, B., Choi, Y., Prokopenko, D., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01415-3 · Cited by 214
Inflammatory biomarkers in Alzheimer's disease plasma
Morgan, A. R., Touchard, S., Leckey, C. A., O’Hagan, C., Nevado‐Holgado, A. J., Barkhof, F., Bertram, L., Blin, O., Bos, I., Dobričić, V., et al. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.03.007 · Cited by 209
Self-citation
Levels of β-Secretase (BACE1) in Cerebrospinal Fluid as a Predictor of Risk in Mild Cognitive Impairment
Zhong, Z., Ewers, M., Teipel, S., Bürger, K., Wallin, A., Blennow, K., He, P., McAllister, C., Hampel, H., & Shen, Y. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.6.718 · Cited by 206
Proinflammatory and anti-inflammatory cytokines in the CSF of patients with Alzheimer's disease and their correlation with cognitive decline
Taipa, R., das Neves, S. P., Sousa, A. L., Fernandes, J., Pinto, C., Correia, A. P., Santos, E., Pinto, P. S., Carneiro, P., Costa, P., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.12.019 · Cited by 205
Physical Exercise in MCI Elderly Promotes Reduction of Pro-Inflammatory Cytokines and Improvements on Cognition and BDNF Peripheral Levels
Nascimento, C. M. C., Pereira, J., de Andrade, L. P., Garuffi, M., Talib, L. L., Forlenza, O. V., Carral, J. M. C., Cominetti, M. R., & Stella, F. (2014) · Current Alzheimer Research · doi:10.2174/156720501108140910122849 · Cited by 195
Plasma MCP-1 and Cognitive Decline in Patients with Alzheimer’s Disease and Mild Cognitive Impairment: A Two-year Follow-up Study
Lee, W., Liao, Y., Wang, Y.-F., Lin, I.-F., Wang, S., & Fuh, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-19807-y · Cited by 197
Peripheral inflammation in prodromal Alzheimer’s and Lewy body dementias
King, E., O'Brien, J. T., Donaghy, P. C., Morris, C. M., Barnett, N. A., Olsen, K., Martin-Ruiz, C. M., Taylor, J., & Thomas, A. J. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-317134 · Cited by 187
Interleukin‐6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus
Fragoso-Loyo, H. E., Richaud‐Patín, Y., Orozco-Narváez, A., Dávila-Maldonado, L., Atisha‐Fregoso, Y., Llorente, L., & Sánchez‐Guerrero, J. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22451 · Cited by 185
Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery
Buccellato, F. R., D’Anca, M., Fenoglio, C., Scarpini, E., & Galimberti, D. (2021) · Antioxidants · doi:10.3390/antiox10091353 · Cited by 179
Self-citation
Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India
Jain, V., Armah, H. B., Tongren, J. E., Ned, R. M., Wilson, N. O., Crawford, S. B., Joel, P. K., Singh, M. P., Nagpal, A. C., Dash, A., et al. (2008) · Malaria Journal · doi:10.1186/1475-2875-7-83 · Cited by 177
Amyloid Deposition and Inflammation in APPswe/PS1dE9 Mouse Model of Alzheimers Disease
Ruan, L., Kang, Z., Pei, G., & Le, Y. (2009) · Current Alzheimer Research · doi:10.2174/156720509790147070 · Cited by 174
Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Current Evidence and Future Perspectives
McGrowder, D. A., Miller, F. G., Vaz, K., Nwokocha, C. R., Wilson-Clarke, C. F., Anderson, M., Brown, J., Anderson-Jackson, L., Williams, L., Latore, L., et al. (2021) · Brain Sciences · doi:10.3390/brainsci11020215 · Cited by 169
Alpha-Synuclein Proteins Promote Pro-Inflammatory Cascades in Microglia: Stronger Effects of the A53T Mutant
Hoenen, C., Gustin, A., Birck, C., Kirchmeyer, M., Beaume, N., Felten, P., Grandbarbe, L., Heuschling, P., & Heurtaux, T. (2016) · PLOS ONE · doi:10.1371/journal.pone.0162717 · Cited by 159
Distinctive Effects of Aerobic and Resistance Exercise Modes on Neurocognitive and Biochemical Changes in Individuals with Mild Cognitive Impairment
Tsai, C., Pai, M., Ukropec, J., & Ukropcová, B. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190228125429 · Cited by 172
Increased production of inflammatory cytokines in mild cognitive impairment
Magaki, S., Mueller, C., DICKSON, C., & Kirsch, W. M. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.09.015 · Cited by 157
Cerebrospinal Fluid Cytokine Levels and Cognitive Impairment in Cerebral Malaria
John, C. C., Panoskaltsis‐Mortari, A., Opoka, R. O., Park, G. S., Orchard, P. J., Jurek, A. M., Idro, R., Byarugaba, J. S., & Boivin, M. J. (2008) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2008.78.198 · Cited by 154
Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research
Janelsins, M. C., Mustian, K. M., Palesh, O. G., Mohile, S. G., Peppone, L. J., Sprod, L. K., Heckler, C. E., Roscoe, J. A., Katz, A. W., Williams, J. P., et al. (2011) · Supportive Care in Cancer · doi:10.1007/s00520-011-1158-0 · Cited by 150
RANTES upregulation in the Alzheimer's disease brain: A possible neuroprotective role
Tripathy, D., Thirumangalakudi, L., & Grammas, P. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.03.009 · Cited by 150
Biomarkers used in Alzheimer’s disease diagnosis, treatment, and prevention
Mahaman, Y. A. R., Embaye, K. S., Huang, F., Li, L., Zhu, F., Wang, J.-Z., Liu, R., Feng, J., & Wang, X. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101544 · Cited by 149
CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer’s disease model
Krauthausen, M., Kummer, M. P., Zimmermann, J., Reyes-Irisarri, E., Terwel, D., Bulic, B., Heneka, M. T., & Müller, M. (2014) · Journal of Clinical Investigation · doi:10.1172/jci66771 · Cited by 152
Biomarkers as Predictors for Conversion from Mild Cognitive Impairment to Alzheimer-Type Dementia: Implications for Trial Design
van Rossum, I. A., Vos, S. J. B., Handels, R. L. H., & Visser, P. J. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091606 · Cited by 148
Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview
Varesi, A., Carrara, A., Pires, V. G., Floris, V., Pierella, E., Savioli, G., Prasad, S., Esposito, C., Ricevuti, G., Chirumbolo, S., et al. (2022) · Cells · doi:10.3390/cells11081367 · Cited by 150
Markers of neuroinflammation associated with Alzheimer’s disease pathology in older adults
Popp, J., Oikonomidi, A., Tautvydaitė, D., Dayon, L., Bacher, M., Migliavacca, E., Henry, H., Kirkland, R., Severin, I., Wojcik, J., et al. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.01.020 · Cited by 136
Distinct cytokine profiles in human brains resilient to Alzheimer's pathology
Barroeta-Espar, I., Weinstock, L. D., Perez-Nievas, B. G., Meltzer, A. C., Siao Tick Chong, M., Amaral, A. C., Murray, M. E., Moulder, K. L., Morris, J. C., Cairns, N. J., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.10.009 · Cited by 133
Inflammatory Markers and Their Association with Post Stroke Cognitive Decline
Narasimhalu, K., Lee, J. H., Leong, Y.-L., Ma, L., Silva, D. A. D., Wong, M.-C., Chang, H., & Chen, C. (2013) · International Journal of Stroke · doi:10.1111/ijs.12001 · Cited by 132
Dietary inulin alters the gut microbiome, enhances systemic metabolism and reduces neuroinflammation in an APOE4 mouse model
Hoffman, J. D., Yanckello, L. M., Chlipala, G. E., Hammond, T. C., McCulloch, S. D., Parikh, I. J., Sun, S., Morganti, J. M., Green, S. J., & Lin, A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0221828 · Cited by 137
Dysregulated Gut Homeostasis Observed Prior to the Accumulation of the Brain Amyloid-β in Tg2576 Mice
Honarpisheh, P., Reynolds, C. R., Conesa, M. P. B., Moruno-Manchon, J. F., Putluri, N., Bhattacharjee, M. B., Urayama, A., McCullough, L. D., & Ganesh, B. P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051711 · Cited by 129
Abnormalities in serum chemokine levels in euthymic patients with Bipolar Disorder
Brietzke, E. M., Kauer‐Sant’Anna, M., Teixeira, A. L., & Kapczinski, F. P. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.04.008 · Cited by 127
Osteopontin is Increased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease and Its Levels Correlate with Cognitive Decline
Comi, C., Carecchio, M., Chiocchetti, A., Nicola, S., Galimberti, D., Fenoglio, C., Cappellano, G., Monaco, F., Scarpini, E., & Dianzani, U. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1309 · Cited by 120
Self-citation
A deficiency in CCR2+ monocytes: the hidden side of Alzheimer’s disease
Naert, G., & Rivest, S. (2013) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjt028 · Cited by 123
Cerebrospinal Fluid Biomarkers of Neurovascular Dysfunction in Mild Dementia and Alzheimer'S Disease
Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.76 · Cited by 122
Longitudinal changes of CSF biomarkers in memory clinic patients
Bouwman, F. H., van der Flier, W. M., Schoonenboom, N. S. M., van Elk, E. J., Kok, A., Rijmen, F., Blankenstein, M. A., & Scheltens, P. (2007) · Neurology · doi:10.1212/01.wnl.0000271375.37131.04 · Cited by 120
Self-citation
Increased plasma levels of lipocalin 2 in mild cognitive impairment
Choi, J., Lee, H., & Suk, K. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.03.023 · Cited by 123
Early intraneuronal amyloid triggers neuron-derived inflammatory signaling in APP transgenic rats and human brain
Welikovitch, L. A., Do Carmo, S., Maglóczky, Z., Malcolm, J. C., Lőke, J., Klein, W. L., Freund, T., & Cuello, A. C. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1914593117 · Cited by 116
Roles of Microglial and Monocyte Chemokines and Their Receptors in Regulating Alzheimer's Disease-Associated Amyloid-β and Tau Pathologies
Guedes, J. R., Lao, T., Cardoso, A. L., & El Khoury, J. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00549 · Cited by 115
Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer’s disease pathogenesis
Dhiman, K., Blennow, K., Zetterberg, H., Martins, R. N., & Gupta, V. B. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03040-5 · Cited by 117
CCL2 Accelerates Microglia-Mediated Aβ Oligomer Formation and Progression of Neurocognitive Dysfunction
Kiyota, T., Yamamoto, M., Xiong, H., Lambert, M. P., Klein, W. L., Gendelman, H. E., Ransohoff, R. M., & Ikezu, T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006197 · Cited by 114
The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer’s but Not Parkinson’s Disease or Dementia with Lewy Bodies
Wennström, M., Surova, Y., Hall, S., Nilsson, C., Minthon, L., Hansson, O., & Nielsen, H. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135458 · Cited by 116
Intravenous Immunoglobulins in Refractory Childhood‐Onset Epilepsy: Effects on Seizure Frequency, EEG Activity, and Cerebrospinal Fluid Cytokine Profile
Billiau, A., Witters, P., Ceulemans, B., Kasran, A., Wouters, C. H., & Lagae, L. G. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01134.x · Cited by 109
Role of interleukin 8 in depression and other psychiatric disorders
Tsai, S. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110173 · Cited by 107
Biomarkers in Sporadic and Familial Alzheimer’s Disease
Lista, S., O’Bryant, S. E., Blennow, K., Dubois, B., Hugon, J., Zetterberg, H., & Hampel, H. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-143006 · Cited by 106
Systemic and Acquired Immune Responses in Alzheimer's Disease
Britschgi, M., & Wyss‐Coray, T. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(07)82011-3 · Cited by 107
Expression Profiles of Cytokines in the Brains of Alzheimer's Disease (AD) Patients Compared to the Brains of Non-Demented Patients with and without Increasing AD Pathology
Morimoto, K., Horio, J., Satoh, H., Sue, L. I., Beach, T. G., Arita, S., Tooyama, I., & Konishi, Y. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101815 · Cited by 105
CXCL4 and CXCL10 Predict Risk of Fatal Cerebral Malaria
Wilson, N. O., Jain, V., Roberts, C. E., Lucchi, N. W., Joel, P. K., Singh, M. P., Nagpal, A. C., Dash, A. P., Udhayakumar, V., Singh, N., et al. (2011) · Disease Markers · doi:10.1155/2011/828256 · Cited by 104
Cerebrospinal Fluid and Plasma Levels of Inflammation Differentially Relate to CNS Markers of Alzheimer’s Disease Pathology and Neuronal Damage
Bettcher, B. M., Johnson, S. C., Fitch, R., Casaletto, K. B., Heffernan, K. S., Asthana, S., Zetterberg, H., Blennow, K., Carlsson, C. M., Neuhaus, J. M., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170602 · Cited by 105
Associations between inflammatory markers and cognitive function in breast cancer patients receiving chemotherapy
Williams, A. M., Shah, R., Shayne, M., Huston, A. J., Krebs, M., Murray, N., Thompson, B. D., Doyle, K., Korotkin, J. E., van Wijngaarden, E., et al. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.10.005 · Cited by 100
Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia
Asevedo, E. D. M., Gadelha, A., Noto, C. D. S., Mansur, R. B., Zugman, A., Belangero, S. I., Berberian, A. D. A., Scarpato, B. S., Leclerc, E., Teixeira, A. L., et al. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.032 · Cited by 101
The complex contribution of chemokines to neuroinflammation: switching from beneficial to detrimental effects
Thuc, O. L., Blondeau, N., Nahon, J., & Rovère, C. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12855 · Cited by 105
Preconditioning of Microglia by α-Synuclein Strongly Affects the Response Induced by Toll-like Receptor (TLR) Stimulation
Roodveldt, C., Labrador‐Garrido, A., González‐Rey, E., Lachaud, C. C., Guilliams, T., Fernández-Montesinos, R., Benitez-Rondan, A., Robledo, G., Hmadcha, A., Delgado, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079160 · Cited by 99
Increased peripheral inflammation in asymptomatic leucine‐rich repeat kinase 2 mutation carriers
Dzamko, N., Rowe, D. B., & Halliday, G. M. (2016) · Movement Disorders · doi:10.1002/mds.26529 · Cited by 98
Transcriptome Changes in the Alzheimer’s Disease Middle Temporal Gyrus: Importance of RNA Metabolism and Mitochondria-Associated Membrane Genes
Piras, I. S., Krate, J., Delvaux, E., Nolz, J., Mastroeni, D., Persico, A. M., Jepsen, W. M., Beach, T. G., Huentelman, M. J., & Coleman, P. D. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181113 · Cited by 100
Role of Chemokines in the Development and Progression of Alzheimer’s Disease
Wojcieszak, J., Kuczyńska, K., & Zawilska, J. B. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02047-1 · Cited by 97
“Levels of CXCL8 were found to be significantly higher in samples, such as brain tissue, plasma, and CSF, obtained from AD patients as compared to healthy controls (Alsadany et al. 2013; Ashutosh et al. 2011; Corrêa et al. 2011; Galimberti et al. 2006; Sokolova et al. 2009).”
BackgroundResultInfluential
The Role of Macrophage Migration Inhibitory Factor in Alzheimer’s Disease
Bacher, M., Deuster, O., Aljabari, B., Egensperger, R., Neff, F., Jessen, F., Popp, J., Noelker, C., Reese, J. P., Al‐Abed, Y., et al. (2010) · Molecular Medicine · doi:10.2119/molmed.2009.00123 · Cited by 92
From Cerebrospinal Fluid to Blood: The Third Wave of Fluid Biomarkers for Alzheimer’s Disease
Zetterberg, H., & Blennow, K. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179926 · Cited by 98
Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration
Galimberti, D., Venturelli, E., Fenoglio, C., Guidi, I., Villa, C., Bergamaschini, L. C., Cortini, F., Scalabrini, D., Baron, P., Vergani, C., et al. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0737-6 · Cited by 94
Self-citation
Mediterranean Diet in Predementia and Dementia Syndromes
Solfrizzi, V., Frisardi, V., Seripa, D., Logroscino, G., Imbimbo, B. P., D’Onofrio, G., Addante, F., Sancarlo, D., Cascavilla, L., Pilotto, A., et al. (2011) · Current Alzheimer Research · doi:10.2174/156720511796391809 · Cited by 98
Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer’s disease
Popp, J., Bacher, M., Kölsch, H., Noelker, C., Deuster, O., Dodel, R. C., & Jessen, F. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.10.006 · Cited by 92
CCL2 affects β-amyloidosis and progressive neurocognitive dysfunction in a mouse model of Alzheimer's disease
Kiyota, T., Gendelman, H. E., Weir, R. A., Higgins, E. E., Zhang, G., & Jain, M. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.08.009 · Cited by 92
Preoperative cerebrospinal fluid cytokine levels and the risk of postoperative delirium in elderly hip fracture patients
Westhoff, D., Witlox, J., Koenderman, L., Kalisvaart, K. J., de Jonghe, J. F. M., van Stijn, M. F. M., Houdijk, A. P. J., Hoogland, I. C. M., MacLullich, A. M. J., van Westerloo, D. J., et al. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-122 · Cited by 90
The Potential Role of Chemokines in Alzheimer’s Disease Pathogenesis
Azizi, G., Hossein‐Khannazer, N., & Mirshafiey, A. (2014) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317513518651 · Cited by 91
Histone Deacetylases Enzyme, Copper, and IL-8 Levels in Patients With Alzheimer’s Disease
Alsadany, M. A., Shehata, H. H., Mohamad, M. I., & Mahfouz, R. (2012) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317512467680 · Cited by 88
Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's Disease
Rosén, C., Andersson, C.-H., Andréasson, U., Molinuevo, J. L., Bjerke, M., Rami, L., Lladó, A., Blennow, K., & Zetterberg, H. (2014) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000362164 · Cited by 88
Innate immune system and inflammation in Alzheimer’s disease: From pathogenesis to treatment
Serpente, M., Bonsi, R., Scarpini, E., & Galimberti, D. (2014) · Neuroimmunomodulation · doi:10.1159/000356529 · Cited by 87
Self-citation
Decreased IL-8 levels in CSF and serum of AD patients and negative correlation of MMSE and IL-1β
Hesse, R., Wahler, A., Gummert, P., Kirschmer, S., Otto, M., Tumani, H., Lewerenz, J., Schnack, C., & von Arnim, C. A. F. (2016) · BMC Neurology · doi:10.1186/s12883-016-0707-z · Cited by 81
Profiling Microglia From Alzheimer’s Disease Donors and Non-demented Elderly in Acute Human Postmortem Cortical Tissue
Alsema, A. M., Jiang, Q., Kracht, L., Gerrits, E., Dubbelaar, M. L., Miedema, A., Brouwer, N., Hol, E. M., Middeldorp, J., van Dijk, R. E., et al. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00134 · Cited by 86
Periodontitis Induced by P. gingivalis-LPS Is Associated With Neuroinflammation and Learning and Memory Impairment in Sprague-Dawley Rats
Hu, Y., Li, H., Zhang, J., Zhang, X., Xia, X., Qiu, C., Liao, Y., Chen, H., Song, Z., & Zhou, W. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00658 · Cited by 81
Pharmacological antagonism of interleukin-8 receptor CXCR2 inhibits inflammatory reactivity and is neuroprotective in an animal model of Alzheimer’s disease
Ryu, J. K., Cho, T., Choi, H. B., Jantaratnotai, N., & McLarnon, J. G. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0339-z · Cited by 82
Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer’s disease
Milà‐Alomà, M., Suárez‐Calvet, M., & Molinuevo, J. L. (2019) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286419888819 · Cited by 81
Association between Helicobacter pylori infection and mild cognitive impairment
Kountouras, J., Tsolaki, M., Boziki, M. K., Gavalas, E., Zavos, C., Stergiopoulos, C., Kapetanakis, N., Chatzopoulos, D., & Venizelos, I. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01827.x · Cited by 80
Activation of the nuclear receptor PPARδ is neuroprotective in a transgenic mouse model of Alzheimer’s disease through inhibition of inflammation
Malm, T., Mariani, M., Donovan, L. J., Neilson, L., & Landreth, G. E. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0229-9 · Cited by 77
Chlamydia pneumoniae: An Etiologic Agent for Late-Onset Dementia
Balin, B. J., Hammond, C. J., Little, C. S., Hingley, S. T., Al-Atrache, Z., Appelt, D. M., Whittum-Hudson, J. A., & Hudson, A. P. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00302 · Cited by 77
Correlation between Serum RANTES Levels and the Severity of Parkinson’s Disease
Tang, P., Li, C., Li, X., Liu, Y., Liu, P., Hou, C., & Li, R. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/208408 · Cited by 77
Blood and CSF chemokines in Alzheimer’s disease and mild cognitive impairment: a systematic review and meta-analysis
Zhou, F., Sun, Y., Xie, X., & Zhao, Y. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01254-1 · Cited by 81
IL-8 Induces Expression of Matrix Metalloproteinases, Cell Cycle and Pro-Apoptotic Proteins, and Cell Death in Cultured Neurons
Thirumangalakudi, L., Yin, L., Rao, H. V., & Grammas, P. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-11307 · Cited by 73
Endoplasmic reticulum stress-regulated CXCR3 pathway mediates inflammation and neuronal injury in acute glaucoma
Ha, Y., Liu, H., Xu, Z., Yokota, H., Narayanan, S. P., Lemtalsi, T., Smith, S. B., Caldwell, R. W., Caldwell, R. B., & Zhang, W. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.281 · Cited by 73
Associations of neuroinflammatory IL-6 and IL-8 with brain atrophy, memory decline, and core AD biomarkers – in cognitively unimpaired older adults
Capogna, E., Watne, L. O., Sørensen, Ø., Guichelaar, C. J., Idland, A., Halaas, N. B., Blennow, K., Zetterberg, H., Walhovd, K. B., Fjell, A. M., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.06.027 · Cited by 73
Tooth loss is associated with mild memory impairment in the elderly: The Fujiwara-kyo study
Okamoto, N., Morikawa, M., Okamoto, K., Habu, N., Hazaki, K., Harano, A., Iwamoto, J., Tomioka, K., Saeki, K., & Kurumatani, N. (2010) · Brain Research · doi:10.1016/j.brainres.2010.06.054 · Cited by 66

Authors: Galimberti, D., Schoonenboom, N., Scheltens, P., Fenoglio, C., Bouwman, F., Venturelli, E., Guidi, I., Blankenstein, M. A., Bresolin, N., & Scarpini, E.
Affiliations: University of Milan (IT)
Vrije Universiteit Amsterdam (NL)
Neurology, Inc (US)
ORCID: Galimberti, Daniela
Schoonenboom, Niki
Scheltens, Philip
Fenoglio, Chiara
Bouwman, Femke
Blankenstein, Marinus A.
Bresolin, Nereo
Scarpini, Elio
Venue: Archives of Neurology
Publisher: American Medical Association (AMA)
Published: 2006-04-01
Volume: 63
Issue: 4
Pages: 538
ISSN: 0003-9942 (ISSN-L)
DOI: 10.1001/archneur.63.4.538
OpenAlex: W2158143414
Cited by: 289
References: 37
Citations by year: 2026: 5 · 2025: 11 · 2024: 13 · 2023: 16 · 2022: 11 · 2021: 24 · 2020: 15 · 2019: 17 · 2018: 11 · 2017: 14 · 2016: 11 · 2015: 13 · 2014: 20 · 2013: 13 · 2012: 15
FWCI: 10.76
Type: journal article
Language: en
Open access: green
pure.amsterdamumc.nl
Licence: other-oa
Locations: Archives of Neurology (publishedVersion)
PubMed (publishedVersion)
Pure Amsterdam UMC (publishedVersion, other-oa)
Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion, other-oa)
Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: Alzheimer's disease, mild cognitive impairment, chemokines, cerebrospinal fluid, CXCL10, MCP-1, interleukin-8, neuroinflammation, disease progression, neurodegeneration, cognitive decline
MeSH terms: Aged, Alzheimer Disease, Brain, Cerebrospinal Fluid Proteins, Cognition Disorders, Encephalitis, Female, Humans, Male, Middle Aged, Neuropsychological Tests, Predictive Value of Tests, Statistics as Topic, Up-Regulation, Interleukin-8, Chemokines, Chemokine CCL2, Chemokines, CXC, Chemokine CXCL10

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Intrathecal Chemokine Synthesis in Mild Cognitive Impairment and Alzheimer Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks